Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines
The US is putting generic medicines on the tariff map, with duties set to rise to as much as 200% in the coming years to boost local manufacturing. But will the cure soothe the pain for American consumers—or inflame it further? Dr Reddy’s Laboratories said that higher import duties will likely push up medicine prices….